Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kropp

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cancer Cell|December 13, 2022
Less, but better: A simplified design for T cell redirection and conditional payload deliveryKorbinian N Kropp, Christopher A Klebanoff
Frontiers in Immunology|March 3, 2020
Modulation of Immune Responses by Platelet-Derived ADAM10Stefanie Maurer, Hans-Georg Kopp, Helmut R Salih, et al.
Plos One|September 9, 2020
A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequencesKorbinian N Kropp, Tim J Schäufele, Martina Fatho, et al.
American Journal of Botany|October 2, 2013
Mutations in GERANYLGERANYL DIPHOSPHATE SYNTHASE 1 affect chloroplast development in Arabidopsis thaliana (Brassicaceae)Nicholas J Ruppel, Kelsey N Kropp, Phillip A Davis, et al.
Frontiers in Immunology|October 18, 2023
Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptorsKorbinian N Kropp, Martina Fatho, Enes Huduti, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancerYanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
Frontiers in Oncology|July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer ProgressionSusanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2018
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphomaKorbinian N Kropp, Stefanie Maurer, Kathrin Rothfelder, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cancer Cell|December 13, 2022
Less, but better: A simplified design for T cell redirection and conditional payload deliveryKorbinian N Kropp, Christopher A Klebanoff
Frontiers in Immunology|March 3, 2020
Modulation of Immune Responses by Platelet-Derived ADAM10Stefanie Maurer, Hans-Georg Kopp, Helmut R Salih, et al.
Plos One|September 9, 2020
A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequencesKorbinian N Kropp, Tim J Schäufele, Martina Fatho, et al.
American Journal of Botany|October 2, 2013
Mutations in GERANYLGERANYL DIPHOSPHATE SYNTHASE 1 affect chloroplast development in Arabidopsis thaliana (Brassicaceae)Nicholas J Ruppel, Kelsey N Kropp, Phillip A Davis, et al.
Frontiers in Immunology|October 18, 2023
Targeting the melanoma-associated antigen CSPG4 with HLA-C*07:01-restricted T-cell receptorsKorbinian N Kropp, Martina Fatho, Enes Huduti, et al.
Diagnostics (Basel, Switzerland)|July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
Platelet-expressed immune checkpoint regulator GITRL in breast cancerYanjun Zhou, Jonas S Heitmann, Kim L Clar, et al.
Frontiers in Oncology|July 25, 2022
Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer ProgressionSusanne M Rittig, Martina S Lutz, Kim L Clar, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2018
The novel deubiquitinase inhibitor b-AP15 induces direct and NK cell-mediated antitumor effects in human mantle cell lymphomaKorbinian N Kropp, Stefanie Maurer, Kathrin Rothfelder, et al.
Pageof 2